Meril last month received an approval from Indian drug regulator Central Drugs Standard Control Organization (CDSCO) for commercialisation of Transcatheter Aortic Heart Valve Replacement, which is sold under the brand name Myval.
Indian device maker Meril Life Sciences joins big league with artificial heart valve technology
Meril last month received an approval from Indian drug regulator Central Drugs Standard Control Organization (CDSCO) for commercialisation of Transcatheter Aortic Heart Valve Replacement, which is sold under the brand name Myval.
